State of Wisconsin Investment Board
CDTX

State of Wisconsin Investment Board’s Cidara Therapeutics CDTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,717
Closed -$1.26M – 2515
2025
Q4 		$1.26M Buy
5,717
+719
+14% +$116K ﹤0.01% 1573
2025
Q3 		$479K Buy
+4,998
New +$319K ﹤0.01% 1920

State of Wisconsin Investment Board's CDTX Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,717 shares — an estimated $1.26M sold.

State of Wisconsin Investment Board first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $1.26M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 5,717 Cidara Therapeutics shares in Q1 2026, an estimated $1.26M.
  • State of Wisconsin Investment Board first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Cidara Therapeutics position peaked at $1.26M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.